0 CHECKOUT

PRODUCT FILTERS

REGION

720
392
389
364
364

COUNTRY

354
48
22
20
19

CATEGORIES

  • 262
  • 252
  • 197
  • 192
  • 183
  • 164
  • 147
  • 145
  • 143
  • 126
  • 117
  • 113
  • 60
  • 58
  • 40

PRICE

157
669
1,166
2,631

PUBLISHED

666
776
1,421
2,631

PRODUCT TYPE

2,512
113
3
2
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Cancer Cell Therapy Market & Pipeline Insight

Since the past 3-5 years, a more complex therapeutic modality has been is emerging as cell therapies which have been developed to treat diseases which are not amenable to treatment with more classical...

Published:  June 2014
Price:  From

Brain Cancer (Glioblastoma Multiforme): Disease and Pipeline Analysis

This report offers a unique therapeutic assessment and in-depth market and pipeline analysis, providing a view of the glioblastoma multiforme (brain cancer) market not available elsewhere. This reports...

Published:  January 2014
Price:  From

Personalizing Cancer Drugs Trends

The report illustrates that understanding of cancer is shifting from a pathology-oriented perspective to a molecular perception Mechanisms responsible for driving cancer continue to emerge in diverse...

Published:  January 2014
Price:  From

Global Cancer Kinase Inhibitors Market & Pipeline Insight

The recent years have witnessed the emergence of kinase inhibitors, which have the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past two decades,...

Published:  October 2014
Price:  From

Global Radiation Therapy Equipment Market 2014-2018

About Radiation Therapy Equipment Radiation therapy equipment is used to perform radiation therapy, also known as radiotherapy or radiation oncology, which is a procedure used in the treatment of cancer...

Published:  March 2014
Price:  From

Cancer Immunotherapy Market & Clinical Pipeline Insight

With more than 6 million deaths worldwide in 2013, cancer has become one of the most pressing health problems faced by almost all the economies of the world Inspite of the fact that there have been...

Published:  July 2014
Price:  From

The Market for Personalized Gene Therapy Treatments for Cancer

In the past, cancer treatments could be painful, invasive and damage the patient's body.   Now there are many novel techniques available for cancer patients that are not as invasive and detrimental...

Published:  December 2014
Price:  From

Global Orphan Cancer Drug Market & Clinical Pipeline Insight

The drug development strategies of the pharmaceutical companies is undergoing a paradigm shift from manufacturing traditional essential medicines to orphan drugs due to significant competition from...

Published:  June 2014
Price:  From

Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017

Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology,...

Published:  May 2013
Price:  From

PD-1/PD-L1 Checkpoint Blockade - Cancer immunotherapy

Immunotherapy as a cancer treatment approach is experiencing a resurgence driven by the FDA approval of ipilimumab (Yervoy), a therapeutic antibody directed at an immune checkpoint protein, CTLA4 Now...

Published:  November 2013
Price:  From

PARP Inhibitors - A new class of targeted cancer therapies

Poly (ADP-ribose) polymerase (PARP) enzymes are involved in repairing DNA PARP inhibition leads to synthetic lethality because only an error prone repair pathway is left to repair DNA damage For this...

Published:  October 2013
Price:  From

Treating Refractory Hematological Malignancies – Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Emerging Therapeutics

Targeting unmet needs in the treatment of cancer through innovative drug development strategies have witnessed favourable outcomes recently New targets have been validated in this process where kinases...

Published:  August 2013
Price:  From

Oncology Drug Funding 2013

A Comprehensive Intelligence Report on Oncology Drug Funding 2013 is first of its kind funding intelligence report, which provides complete landscape on cancer drug funding starting from early, mid...

Published:  September 2013
Price: 

CAS Hydroxyurea World Consumption Report

This CAS Hydroxyurea World Consumption Report provides data on the net consumption of CAS 127-07-1 - Hydroxyurea Substance(s) in each of the countries listed. The Substance(s) covered (Hydroxyurea )...

Published:  February 2016
Price: 

CAS Melphalan World Consumption Report

This CAS Melphalan World Consumption Report provides data on the net consumption of CAS 148-82-3 - Melphalan Substance(s) in each of the countries listed. The Substance(s) covered (Melphalan ) are classified...

Published:  February 2016
Price: 

CAS Megestrol acetate World Consumption Report

This CAS Megestrol acetate World Consumption Report provides data on the net consumption of CAS 595-33-5 - Megestrol acetate Substance(s) in each of the countries listed. The Substance(s) covered (Megestrol...

Published:  February 2016
Price: 

CAS Vinblastine sulfate World Consumption Report

This CAS Vinblastine sulfate World Consumption Report provides data on the net consumption of CAS 143-67-9 - Vinblastine sulfate Substance(s) in each of the countries listed. The Substance(s) covered...

Published:  February 2016
Price: 

CAS Vinblastine World Consumption Report

This CAS Vinblastine World Consumption Report provides data on the net consumption of CAS 865-21-4 - Vinblastine Substance(s) in each of the countries listed. The Substance(s) covered (Vinblastine )...

Published:  February 2016
Price: 

CAS Lithium carbonate World Consumption Report

This CAS Lithium carbonate World Consumption Report provides data on the net consumption of CAS 554-13-2 - Lithium carbonate Substance(s) in each of the countries listed. The Substance(s) covered (Lithium...

Published:  February 2016
Price: 

CAS Estradiol valerate World Consumption Report

This CAS Estradiol valerate World Consumption Report provides data on the net consumption of CAS 979-32-8 - Estradiol valerate Substance(s) in each of the countries listed. The Substance(s) covered...

Published:  February 2016
Price: 
Loading Indicator

Our Clients